Published in Eur J Clin Microbiol Infect Dis on December 01, 1997
Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis (2003) 1.87
Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (2011) 1.43
Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur J Clin Microbiol Infect Dis (2004) 1.12
Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey. Eur J Epidemiol (2000) 1.06
Alcaligenes xylosoxidans endocarditis of a prosthetic valve and pacemaker in a 62-year-old woman. Tex Heart Inst J (2013) 0.96
Fluorescent whole-cell hybridization with 16S rRNA-targeted oligonucleotide probes to identify Brucella spp. by flow cytometry. J Clin Microbiol (2000) 0.75
Intracardiac abscess with cutaneous fistula secondary to ventricular septal defect repair simulating sternal wound infection. Tex Heart Inst J (2014) 0.75
Achromobacter xylosoxidans Septic Arthritis in a Child with Primary Immunodeficiency. J Glob Infect Dis (2017) 0.75
Catheter-associated sepsis caused by Ochrobactrum anthropi: report of a case and review of related nonfermentative bacteria. Clin Infect Dis (1992) 2.70
Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxydans by DNA restriction fragment length polymorphism. J Clin Microbiol (1994) 2.60
Bacteremia due to Achromobacter xylosoxidans in patients with cancer. Clin Infect Dis (1992) 2.57
Ochrobactrum anthropi bacteremia: report of four cases and short review. Infection (1994) 2.13
Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis (1996) 2.09
Infections with the unusual human pathogens Agrobacterium species and Ochrobactrum anthropi. Clin Infect Dis (1994) 1.83
In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob Agents Chemother (1988) 1.47
Catheter-associated sepsis due to Alcaligenes xylosoxidans in a child with AIDS. Clin Infect Dis (1993) 1.45
Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis (1996) 1.31
Achromobacter xylosoxidans bacteremia. Rev Infect Dis (1988) 1.26
Seven cases of bacteremia due to Ochrobactrum anthropi. Clin Infect Dis (1992) 1.23
Agrobacterium infections in humans: experience at one hospital and review. Clin Infect Dis (1993) 1.16
An outbreak of Ochrobactrum anthropi bacteraemia in five organ transplant patients. J Hosp Infect (1994) 1.16
Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors. Eur J Clin Microbiol Infect Dis (1996) 1.06
The in-vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 40 antimicrobial agents. J Antimicrob Chemother (1990) 1.03
Opportunistic nosocomial multiply resistant bacterial infections--their treatment and prevention. J Antimicrob Chemother (1993) 1.01
Bacteremia caused by Ochrobactrum anthropi in an immunocompromised child. Infection (1995) 0.98
Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients. J Infect Dis (1996) 0.94
Achromobacter xylosoxidans. An unusual neonatal pathogen. Am J Clin Pathol (1991) 0.93
Prosthetic knee infection due to Achromobacter xylosoxidans. J Rheumatol (1992) 0.91
Agrobacterium radiobacter bacteremia in a child with human immunodeficiency virus infection. Pediatr Infect Dis J (1991) 0.91
Bacteremia at a Danish university hospital during a twenty-five-year period (1968-1992). Scand J Infect Dis (1995) 0.91
Meningitis caused by Alcaligenes (Achromobacter) xylosoxidans associated with epidural catheter. Infection (1996) 0.90
Infection by Alcaligenes xylosoxidans subsp. xylosoxidans in neutropenic patients. Oncology (1996) 0.83
Pulmonary abscess associated with Alcaligenes xylosoxidans in a patient with AIDS. Clin Infect Dis (1993) 0.82
Bacterial infections. Med Clin North Am (1997) 0.79
Achromobacter xylosoxidans (Alcaligenes xylosoxidans subspecies xylosoxidans) bacteremia after liver transplantation. Intensive Care Med (1993) 0.79
[Community-acquired and nosocomial septicemias in patients with human immunodeficiency virus infection]. Presse Med (1996) 0.78
Agrobacterium radiobacter pneumonia in a patient with HIV infection. Eur J Clin Microbiol Infect Dis (1996) 0.77
Achromobacter xylosoxidans bacteremia. Infect Control Hosp Epidemiol (1990) 0.75
Nosocomial neonatal meningitis by Alcaligenes xylosoxidans transmitted by aqueous eosin. Pediatr Infect Dis J (1993) 0.75
Alcaligenes xylosoxidans subsp xylosoxidans in children with chronic otorrhea. Otolaryngol Head Neck Surg (1996) 0.75
Alcaligenes xylosoxidans-associated infection in an infant with cholesteatoma. Pediatr Infect Dis J (1995) 0.75
[Alcaligenes denitrificans subsp. xylosoxidans infection in a patient with corticodependent chronic respiratory insufficiency]. Presse Med (1996) 0.75
Nosocomial infection by Alcaligenes xylosoxidans in neutropenic patients. Presse Med (1995) 0.75
Performance assessment of new multiplex probe assay for identification of mycobacteria. J Clin Microbiol (2001) 2.68
Aortic arch anomalies are associated with increased risk of neurological events in carotid stent procedures. Eur J Vasc Endovasc Surg (2007) 1.73
Use of the internet for self-education by patients with prostate cancer. Urology (2001) 1.57
Isolated detection of cryptococcal polysaccharide antigen in cerebrospinal fluid samples from patients with AIDS. Clin Infect Dis (1996) 1.50
Abdominal lymphadenopathy detected by ultrasonography in HIV-1 infection: prevalence and significance. Scand J Infect Dis (1993) 1.44
Staphylococcus cohnii: an unusual cause of primary septic arthritis in a patient with AIDS. Clin Infect Dis (1996) 1.43
Use of an Exotic Carbon Source To Selectively Increase Metabolic Activity and Growth of Pseudomonas putida in Soil. Appl Environ Microbiol (1993) 1.43
Progressive multifocal leucoencephalopathy in AIDS: treatment with cytosine arabinoside. AIDS (1995) 1.43
Treatment of partial losses of the helix. Plast Reconstr Surg (1998) 1.41
Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection (2004) 1.37
Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J (1993) 1.36
Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel and immigration. Eur J Epidemiol (1994) 1.31
Resection of the suprarenal inferior vena cava. The role of prosthetic replacement. Arch Surg (1995) 1.24
Surgical care in octogenarians. Br J Surg (1996) 1.22
Flavobacterium spp. organisms as opportunistic bacterial pathogens during advanced HIV disease. J Infect (1999) 1.21
Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev (2005) 1.21
Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) (1983) 1.17
Enhanced growth and activity of a biocontrol bacterium genetically engineered to utilize salicylate. Appl Environ Microbiol (1993) 1.11
Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet (1989) 1.11
A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS (2000) 1.10
Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chemother (1998) 1.09
Psychosocial treatment for opiate abuse and dependence. Cochrane Database Syst Rev (2005) 1.08
Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey. Eur J Epidemiol (2000) 1.06
Vertical transmission of HTLV-III. Lancet (1986) 1.06
Outcomes for early rectal cancer managed with transanal endoscopic microsurgery: a 5-year follow-up study. Surg Endosc (2006) 1.05
Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death? Br Heart J (1988) 1.05
Iliac osteomyelitis and gluteal muscle abscess caused by Streptococcus intermedius. J Med Microbiol (2001) 1.02
Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev (2004) 1.02
Surgical treatment of adenocarcinoma of the cardia. Surgery (1992) 1.00
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis. J Antimicrob Chemother (1998) 1.00
Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences. Eur J Surg Oncol (2010) 0.99
Giant infrarenal aortic aneurysm: a huge size of 15 cm on diameter. Minerva Chir (2009) 0.99
Virus-induced autoimmunity in hepatitis C virus infections: a rare event. J Med Virol (1994) 0.99
Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART. Infection (2002) 0.99
Involvement of mitochondrial protein synthesis in sporulation: effects of erythromycin on macromolecular synthesis, meiosis, and ascospore formation in Saccharomyces cerevisiae. J Bacteriol (1983) 0.96
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. QJM (2004) 0.96
Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Biol Psychiatry (2000) 0.96
Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report. J Chemother (2001) 0.95
Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev (2004) 0.94
Academic performance in children with rolandic epilepsy. Dev Med Child Neurol (2008) 0.93
Doxycycline and chloroquine as treatment for chronic Q fever endocarditis. J Infect (2002) 0.93
A combination of pirenzepine and cimetidine: a new approach to treatment of duodenal ulcer in "non-responders". Hepatogastroenterology (1985) 0.91
Liver autoreactivity in acute virus A, B and non-A, non-B hepatitis. J Clin Lab Immunol (1988) 0.91
Chickenpox complications among immunocompetent hospitalized children in Italy. Acyclovir-Chickenpox Italian Study Group. Pediatr Med Chir (1997) 0.91
Common carotid agenesis and internal carotid stenting. Int Angiol (2007) 0.90
[AIDS-related cryptococcosis: diagnostic aspects, prognostic and therapeutic implications]. Ann Ital Med Int (1998) 0.90
Ochrobactrum anthropi as an agent of nosocomial septicemia in the setting of AIDS. Clin Infect Dis (1999) 0.90
Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Infection (2003) 0.90
Detection of circulating p24 antigen-positive CD4+ cells during HIV infection by flow cytometry. AIDS (1992) 0.89
Primary cytomegalovirus infection in otherwise healthy adults with Fever of unknown origin: a 3-year prospective survey. Infection (2006) 0.89
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication. J Infect Dis (1997) 0.89
The effects of alternative treatments for HIV disease on recommended pharmacological regimens. Int J Antimicrob Agents (2000) 0.89
Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study. Med Oncol Tumor Pharmacother (1989) 0.89
Emerging gram-negative pathogens in the immunocompromised host: Agrobacterium radiobacter septicemia during HIV disease. New Microbiol (1999) 0.88
Fatal Campylobacter jejuni bacteraemia in patients with AIDS. J Med Microbiol (1999) 0.88
Quality of life and life expectancy in thalassemic patients with complications. Prog Clin Biol Res (1989) 0.87
Community-acquired pneumonia due to Staphylococcus cohnii in an HIV-infected patient: case report and review. Eur J Clin Microbiol Infect Dis (1995) 0.87
gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol Clin Exp Res (1992) 0.87
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group. Antimicrob Agents Chemother (2000) 0.87
A comparison of immunocomplex-dissociated serum HIV-1 p24 antigenemia and plasma HIV-1 viral load: assessment of 3,129 paired assays. New Microbiol (1999) 0.86
The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review. Mycopathologia (1999) 0.86
Neuroendocrine correlates of temperament traits in abstinent opiate addicts. J Subst Abuse (2000) 0.86
Histoplasma capsulatum var. capsulatum occurring in an HIV-positive Ghanaian immigrant to Italy. Identification of H. capsulatum DNA by PCR from paraffin sample. APMIS (2001) 0.85
Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study. HIV Med (2004) 0.85
[Hemoperitoneum caused by cavernous angioma of the omentum]. Minerva Chir (1989) 0.85
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure. Mycopathologia (2004) 0.85
The importance of symptom duration in relation to prognosis of carcinoma of the large intestine. Surg Gynecol Obstet (1984) 0.85
Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev (2002) 0.84
Another emerging event occurring during HIV infection treated with any antiretroviral therapy: frequency and role of gynecomastia. Infez Med (2004) 0.84
A novel frame-shift deletion causing analbuminaemia in an Italian paediatric patient. Eur J Clin Invest (2010) 0.84
Acinetobacter infections in patients with human immunodeficiency virus infection: microbiological and clinical epidemiology. Chemotherapy (2001) 0.84
Osteonecrosis and highly active antiretroviral therapy during HIV infection: report of a series and literature review. AIDS Patient Care STDS (2001) 0.84
Moraxella catarrhalis pneumonia during HIV disease. J Chemother (2000) 0.83
Community-acquired Pseudomonas aeruginosa sacro-iliitis in a previously healthy patient. J Med Microbiol (2002) 0.83
C-reactive protein elevation and early outcome in patients with unstable angina pectoris. Am J Cardiol (1997) 0.83
Capnocytophaga spp. brain abscess in an immunocompetent host: problems in antimicrobial chemotherapy and literature review. J Chemother (2004) 0.83
Anti-hepatitis C virus antibodies amongst Italian homo-bisexual males. Eur J Epidemiol (1992) 0.83
Typhoid fever and HIV infection: a rare disease association in industrialized countries. Int J Infect Dis (1999) 0.83
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. J Infect Dis (2000) 0.82
Disseminated histoplasmosis with atypical cutaneous lesions in an Italian HIV-infected patient: another autochtonous case. HIV Med (2003) 0.82
Sepsis-bacteraemia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection. Clin Ter (1993) 0.82